• linkedin
  • Increase Font
  • Sharebar

    FDA investigates safety of testosterone products

    No conclusion reached yet

    The FDA said it is investigating the risk of stroke, heart attack, and death in men taking FDA-approved testosterone products.

    In a Jan. 31 safety announcement, the agency said it “has not concluded that FDA-approved testosterone treatment increases the risk of stroke, heart attack, or death.”

    It also cautioned that patients “should not stop taking prescribed testosterone products without first discussing any questions or concerns with their healthcare professionals.”

    The investigation was prompted by the recent publication of two recent studies.

    “We are providing this alert while we continue to evaluate the information from these studies and other available data, and will communicate our final conclusions and recommendations when the evaluation is complete,” the FDA said.



    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available